scholarly journals Characteristics of Residual Symptoms in Korean Patients with Major Depressive Disorder: A Validation Study for the Korean Version of Depression Residual Symptom Scale

2018 ◽  
Vol 15 (2) ◽  
pp. 178-185
Author(s):  
Sol A Park ◽  
Sang Won Jeon ◽  
Ho-Kyoung Yoon ◽  
Seo Young Yoon ◽  
Cheolmin Shin ◽  
...  
2018 ◽  
Vol 49 (11) ◽  
pp. 1869-1878 ◽  
Author(s):  
Boadie W. Dunlop ◽  
Philip E. Polychroniou ◽  
Jeffrey J. Rakofsky ◽  
Charles B. Nemeroff ◽  
W. Edward Craighead ◽  
...  

AbstractBackgroundPersisting symptoms after treatment for major depressive disorder (MDD) contribute to ongoing impairment and relapse risk. Whether cognitive behavior therapy (CBT) or antidepressant medications result in different profiles of residual symptoms after treatment is largely unknown.MethodsThree hundred fifteen adults with MDD randomized to treatment with either CBT or antidepressant medication in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study were analyzed for the frequency of residual symptoms using the Montgomery Asberg Depression Rating Scale (MADRS) item scores at the end of the 12-week treatment period. Separate comparisons were made for treatment responders and non-responders.ResultsAmong treatment completers (n= 250) who responded to CBT or antidepressant medication, there were no significant differences in the persistence of residual MADRS symptoms. However, non-responders treated with medication were significantly less likely to endorse suicidal ideation (SI) at week 12 compared with those treated with CBT (non-responders to medication: 0/54, 0%, non-responders to CBT: 8/30, 26.7%;p= .001). Among patients who terminated the trial early (n= 65), residual MADRS item scores did not significantly differ between the CBT- and medication-treated groups.ConclusionsDepressed adults who respond to CBT or antidepressant medication have similar residual symptom profiles. Antidepressant medications reduce SI, even among patients for whom the medication provides little overall benefit.


2021 ◽  
Vol 11 (1) ◽  
pp. 8
Author(s):  
Carol S. North ◽  
David Baron

Agreement has not been achieved across symptom factor studies of major depressive disorder, and no studies have identified characteristic postdisaster depressive symptom structures. This study examined the symptom structure of major depression across two databases of 1181 survivors of 11 disasters studied using consistent research methods and full diagnostic assessment, addressing limitations of prior self-report symptom-scale studies. The sample included 808 directly-exposed survivors of 10 disasters assessed 1–6 months post disaster and 373 employees of 8 organizations affected by the September 11, 2001 terrorist attacks assessed nearly 3 years after the attacks. Consistent symptom patterns identifying postdisaster major depression were not found across the 2 databases, and database factor analyses suggested a cohesive grouping of depression symptoms. In conclusion, this study did not find symptom clusters identifying postdisaster major depression to guide the construction and validation of screeners for this disorder. A full diagnostic assessment for identification of postdisaster major depressive disorder remains necessary.


2018 ◽  
Vol 262 ◽  
pp. 469-476 ◽  
Author(s):  
Gianluca Serafini ◽  
Jacopo Nebbia ◽  
Nicolò Cipriani ◽  
Claudia Conigliaro ◽  
Denise Erbuto ◽  
...  

2010 ◽  
Vol 28 (2) ◽  
pp. 137-144 ◽  
Author(s):  
Nadia Iovieno ◽  
Adrienne van Nieuwenhuizen ◽  
Alisabet Clain ◽  
Lee Baer ◽  
Andrew A. Nierenberg

2012 ◽  
Vol 9 (4) ◽  
pp. 391 ◽  
Author(s):  
Min-Soo Lee ◽  
Yong Min Ahn ◽  
Seockhoon Chung ◽  
Richard Walton ◽  
Joel Raskin ◽  
...  

2017 ◽  
Vol 15 (4) ◽  
pp. 391-401
Author(s):  
Young Sup Woo ◽  
Roger S. McIntyre ◽  
Jung-Bum Kim ◽  
Min-Soo Lee ◽  
Jae-Min Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document